Alzex Neuropharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Feb '26 Feb 5, 2026	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007
Market Capitalization	0	0	1	0	6	-
Market Cap Growth	-99.94%	-63.78%	174.42%	-91.75%	-	-
Enterprise Value	-	1	2	2	7	-
Last Close Price	0.00	240.00	900.01	1500.02	18000.18	-
PE Ratio	0.01	14.51	16.10	-	25.46	-
PS Ratio	0.00	0.10	0.34	0.05	0.38	-
PB Ratio	0.00	0.45	1.07	0.75	17.18	-
P/FCF Ratio	-	1.62	17.85	-	16.53	-
P/OCF Ratio	0.00	1.62	17.85	-	15.87	-
EV/Sales Ratio	-	0.23	0.63	0.20	0.49	-
EV/EBITDA Ratio	-	118.32	13.13	-	-	-
EV/EBIT Ratio	-	-	21.37	-	-	-
EV/FCF Ratio	-	3.81	33.47	-	21.29	-
Debt / Equity Ratio	0.60	0.60	0.70	2.13	4.21	-39.98
Debt / EBITDA Ratio	67.41	67.41	4.56	-	-	-
Debt / FCF Ratio	2.17	2.17	11.64	-	4.05	1.45
Asset Turnover	2.25	2.25	1.70	4.13	6.96	6.99
Quick Ratio	1.40	1.40	1.82	2.70	1.47	2.16
Current Ratio	1.43	1.43	1.91	2.72	1.53	2.28
Return on Equity (ROE)	2.85%	2.85%	8.75%	-69.49%	157.92%	-206.92%
Return on Assets (ROA)	-1.64%	-1.64%	3.14%	-7.95%	-6.10%	-9.76%
Return on Capital Employed (ROCE)	-3.30%	-3.30%	5.40%	-13.30%	-12.20%	-18.00%
Earnings Yield	7091.37%	6.89%	6.21%	-70.64%	3.93%	-
FCF Yield	-	61.58%	5.60%	-50.93%	6.05%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.